CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 30, 2022
Current Assets:
Cash and cash equivalents	$ 48,696	$ 48,723
Short term investments	32	32
Accounts receivable – net	4,161	4,336
Accounts receivable - related party	90
Medical receivable – net	19,216	20,109
Management and other fees receivable – net	34,582	33,419
Management and other fees receivable – related medical practices – net	8,723	8,603
Inventories	2,458	2,360
Prepaid expenses and other current assets	1,108	1,104
Total Current Assets	119,066	118,686
Accounts receivable – long term	1,575	1,872
Deferred income tax asset	11,697	12,843
Property and equipment – net	22,207	22,282
Right-of-use Asset – operating lease	34,180	34,232
Right-of-use Asset – financing lease	878	928
Goodwill	4,269	4,269
Other intangible assets – net	3,624	3,704
Other assets	526	526
Total Assets	198,022	199,342
Current Liabilities:
Current portion of long-term debt and capital leases	42	40
Accounts payable	773	1,552
Other current liabilities	5,201	6,417
Unearned revenue on service contracts	4,123	4,289
Unearned revenue on service contracts – related party	82
Operating lease liability - current portion	3,908	3,880
Financing lease liability - current portion	212	210
Customer deposits	532	361
Total Current Liabilities	14,873	16,749
Long-Term Liabilities:
Unearned revenue on service contracts	1,576	1,857
Deferred income tax liability	216	216
Due to related medical practices	93	93
Operating lease liability – net of current portion	33,112	33,091
Financing lease liability – net of current portion	784	838
Long-term debt and capital leases, less current portion	148	155
Other liabilities	90	107
Total Long-Term Liabilities	36,019	36,357
Total Liabilities	50,892	53,106
STOCKHOLDERS' EQUITY:
Class A non-voting preferred stock $.0001 par value; 453 shares authorized at September 30, 2022 and June 30, 2022, 313 issued and outstanding at September 30, 2022 and June 30, 2022
Preferred stock $.001 par value; 567 shares authorized at September 30, 2022 and June 30, 2022, issued and outstanding – none
Common Stock $.0001 par value; 8,500 shares authorized at September 30, 2022 and June 30, 2022, 6,566 issued at September 30, 2022 and June 30, 2022, 6,545 and 6,554 outstanding at September 30, 2022 and June 30, 2022, respectively	1	1
Class B Common Stock (10 votes per share) $.0001 par value; 227 shares authorized at September 30, 2022 and June 30, 2022; .146 issued and outstanding at September 30, 2022 and June 30, 2022
Class C Common Stock (25 votes per share) $.0001 par value; 567 shares authorized at September 30, 2022 and June 30, 2022, 383 issued and outstanding at September 30, 2022 and June 30, 2022
Paid-in capital in excess of par value	184,531	184,531
Accumulated deficit	(31,520)	(33,567)
Treasury stock, at cost – 20 shares of common stock at September 30, 2022 and 12 shares of common stock at June 30, 2022	(797)	(675)
Total Fonar Corporation’s Stockholders’ Equity	152,215	150,290
Noncontrolling interests	(5,085)	(4,054)
Total Stockholders' Equity	147,130	146,236
Total Liabilities and Stockholders' Equity	$ 198,022	$ 199,342